News

In a perfect world, equivalent responses to treatments from patients with pulmonary hypertension would make all treatment outcomes predictable and highly effective. In reality, this is not the case. However, distinguishing subtypes of pulmonary arterial hypertension can at least improve treatment outcomes by better matching patients to treatments using…

The ViScope MD – photo courtesy of HD Medical, Inc. Patients with pulmonary hypertension exhibit a number of symptoms that often lead physicians to believe the problem is confined to the lungs, making PH one of the most misdiagnosed, potentially life-threatening diseases today. Some patients…

The country’s leading source of pulmonary hypertension patient and research support, the Pulmonary Hypertension Association, is hosting the first O2 Breathe Hearts PHor Hope Gala this month. The benefit will be spearheaded by the association’s Midwest Chapter to raise funds and awareness for this rare, life-altering, and…

At the recent American College of Chest Physicians’ (ACCP) meeting, Darren Taichman, MD, PhD, executive deputy editor of the Annals of Internal Medicine, together with a colleague, presented updated information concerning diagnosis and treatment of pulmonary hypertension, based on what is known as evidence-based clinical practice guidelines.

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) who respond differently to treatment with pulmonary endarterectomy (PEA) may have differences in microvascular structure. When a team of researchers from Paris-South University and Centre Chirugical Marie Lannelongue investigated CTEPH pathogenesis in humans, they applied their findings related to microvasculature changes…

While the majority of individuals suspected of having pulmonary hypertension would prefer to receive a physical examination to confirm diagnosis, invasive right heart catheterization may still offer the most reliable indication of diagnosis. “Utility of the Physical Examination in Detecting Pulmonary Hypertension: A Mixed Methods…

A research team from the University of Alberta, led by Dr. Evengelos Michelakis, claims to have found a link between Pulmonary Hypertension, diabetes, and cancer. PAH is a disease caused by a constriction of the arteries in the lung, forcing the right heart ventricle to work intensely. This causes…

In a study entitled “A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study” published in the November issue of  Annals of the Rheumatic Diseases journal, the authors sought to understand the effects of gender on the systemic sclerosis phenotype…

In a recent study entitled “Accuracy of invasive arterial pressure monitoring in cardiovascular patients: an observational study” the authors suggest that when evaluating a patient’s cardiovascular system, a non-invasive blood pressure measurement may be more accurate than the standard invasive method to measure arterial pressure. Improved…

The Baltimore Walk for Hope is an upcoming event organized by the Pulmonary Hypertension Association (PHA) to raise awareness about pulmonary hypertension. The event will take place next Sunday, November 2nd at the Baltimore Zoo. The event is designed to be a 1.1 mile family and friendly walk…

In a study entitled “Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease” recently published in BMC Pulmonary Medicine, the authors of the research describe how their newly developed mean response time (MRT) index (wMRT), which is based on measuring oxygen uptake…

Naturally occurring microRNA molecules (miRNA) hold the potential to be a new treatment for pulmonary artery disease. A group at Sookmyung University and Yale University led by Professor Kim Jong-min investigated the causes of pulmonary arterial hypertension and discovered new molecular mechanism contributing to the disease. “Our research is…